Artivion | CRY - Eps Gewinn Pro Aktie

Aktienkurs
35.29
Täglich Wechseln
-1.10 -3.02%
Monatlich
-8.46%
Jährlich
45.53%
Q1 Prognose
35.04




Eps Veränderung Datum
Abbott USD 1.5 0.2 2025-12
Accuray USD 0.02 0.06 2024-12
AngioDynamics USD -0.07 0.13 2025-09
Artivion USD -0.02 0.2 2025-12
AtriCure USD 0.06 0.07 2025-12
Baxter International USD 0.44 0.25 2025-12
Becton, Dickinson and Co. USD 2.91 1.05 2025-12
Boston Scientific USD 0.8 0.05 2025-12
Edwards Lifesciences USD 0.58 0.09 2025-12
Inogen USD -0.25 0.01 2024-09
Integra LifeSciences USD 0.83 0.29 2025-12
J&J USD 2.46 0.34 2025-12
Mesa Laboratories USD -0.31 0.94 2024-12
Orthofix International USD 0.08 0.12 2025-12
Pfizer USD 0.66 0.21 2025-12
ResMed USD 2.81 0.26 2025-12
Stryker USD 4.47 1.28 2025-12
Surmodics USD -0.25 0.28 2024-09
Tandem Diabetes Care USD -0.01 0.3 2025-12
Teleflex USD 1.93 1.74 2025-12
Terumo JPY 22.14 1.62 2025-12
Trinity Biotech USD -0.28 0.96 2025-09